NEWS & MEDIA
January 1, 2018
The Glycogen synthase kinase-3 inhibitor, 9-ING-41, synergize with chemotherapy to inhibit pancreatic tumor growth in vivo
January 1, 2018
Glycogen Synthase Kinase-3β Inhibition Attenuates the Progression of Pulmonary Fibrosis
PARTNERING
As we continue to develop novel therapies to improve outcomes for patients. We are open to new partnerships with academic and scientific organizations.